| Enterprise Software Leaders Build AI Agents With NVIDIA |
Globe Newswire |
06/01 |
00:21 |
| NIO Inc. Provides May 2026 Delivery Update |
Globe Newswire |
06/01 |
00:01 |
| NVIDIA Unveils Vera, the CPU for Agents |
Globe Newswire |
05/31 |
23:57 |
| NVIDIA Vera BlueField-4 STX Brings Agentic AI Storage Processing With In-Silicon Security |
Globe Newswire |
05/31 |
23:47 |
| NVIDIA Vera Rubin Ramps Into Full Production to Power Agentic AI Factories Worldwide |
Globe Newswire |
05/31 |
23:43 |
| NVIDIA DSX Gives Infrastructure Builders the Playbook for AI Factories |
Globe Newswire |
05/31 |
23:30 |
| Crypto Meets Wall Street: MEXC Unveils 'RealStocks' with 0-Fee U.S. Equity Trading and Real Dividends |
Globe Newswire |
05/31 |
22:00 |
| Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026 |
Globe Newswire |
05/31 |
19:30 |
| The SpaceX Roadshow Is Expected to Launch in Days. A Wall Street Veteran Says What You Learn Before It Starts Matters More Than Anything That Comes After |
Globe Newswire |
05/31 |
18:27 |
| Glyco Harmony Drops [URGENT REPORT 2026] GlycoHarmony Shocking Complete Scientific Breakdown of Benefits Everyone Is Talking |
Globe Newswire |
05/31 |
14:38 |
| Melt Drops [URGENT REPORT 2026] MeltDrops Shocking Boom Why Everyone Is Talking About This Weight Loss Supplement |
Globe Newswire |
05/31 |
14:09 |
| SlimTide Capsules [SHOCKING REPORT 2026] Slim Tide Latest Viral Weight-Loss Supplement Craze, Counterfeit Market Explosion, and Consumer Safety Concerns |
Globe Newswire |
05/31 |
13:24 |
| Sublime AI Law Mastery Unveiled to Resolve Historic Camp Lejeune Backlog (Veterans First For America) |
Globe Newswire |
05/31 |
11:54 |
| James Altucher Spent Months Researching the Technology Behind the SpaceX IPO. He Put Everything Into One Presentation and Released It for Free |
Globe Newswire |
05/31 |
09:25 |
| Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer |
Globe Newswire |
05/31 |
09:00 |
| Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer |
Globe Newswire |
05/31 |
08:06 |
| Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma |
Globe Newswire |
05/31 |
08:00 |
| NeuExcell Therapeutics Announces Encouraging Data of NXL-004 in Recurrent Malignant Glioma at 2026 ASCO |
Globe Newswire |
05/31 |
06:00 |
| James Altucher Just Released a Free Presentation He Says Could Be the Most Important 30 Minutes You Watch Before June |
Globe Newswire |
05/30 |
21:22 |
| Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology |
Globe Newswire |
05/30 |
14:30 |
| Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial |
Globe Newswire |
05/30 |
14:15 |
| Global Times: China demonstrates remarkable ability to set a long-term vision and actually execute it |
Globe Newswire |
05/30 |
12:33 |
| Vapofil Reviews [URGENT REPORT 2026] The Shocking VapoFil Male Enhancement Supplement Trend Everyone Is Talking About |
Globe Newswire |
05/30 |
10:27 |
| World Vape Day 2026: One Switch – Everyone Wins |
Globe Newswire |
05/30 |
10:00 |
| ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026 |
Globe Newswire |
05/30 |
10:00 |
